Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods.
Francisco López-MedranoMaría Muñoz de la EspadaMaría Asunción Pérez-Jacoiste AsínMario Fernández-RuizJuan María Herrero-MartínezJesús Alonso-CarrilloRafael San JuanIsabel Rodríguez-GoncerAmado AndrésEsther GonzálezAlejandro ManriqueIago JustoAlberto MarcacuzcoCarmelo Loinaz-SegurolaCarlos JiménezCarlos Lumbreras-BermejoJose María AguadoPublished in: Mycoses (2022)
This retrospective study did not reveal a significant benefit from the initial use of micafungin-based antifungal prophylaxis over fluconazole among PTRs in terms of invasive candidiasis.